WITHDRAWN:Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission

McChalicher, C.W., Lombardo, M., Khanna, S., McKenzie, G.J., McGovern, B.H., Auniņš, J.G. (2023). WITHDRAWN:Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission. https://doi.org/10.1016/j.gastha.2023.01.018

McChalicher, Christopher W.J., et al.. "WITHDRAWN:Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission". CrossRef, 2023. doi:10.1016/j.gastha.2023.01.018.

@article{mcchalicher2023, author = {Christopher W.J. McChalicher and Mary-Jane Lombardo and Sahil Khanna and Gregory J. McKenzie and Barbara H. McGovern and John G. Auniņš}, title = {WITHDRAWN:Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission}, year = {2023}, journal = {CrossRef}, doi = {10.1016/j.gastha.2023.01.018}, url = {https://doi.org/10.1016/j.gastha.2023.01.018}, }

WITHDRAWN:Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission

Penulis (6)

Format Sitasi

Akses Cepat